Momenta Pharmaceuticals Announces Publication Revealing Development of a …

Momenta Pharmaceuticals Announces Publication Revealing Development of a …

The article summarizes Momenta's progress in creating a hsIVIg drug candidate with the potential for more consistent and enhanced anti-inflammatory activity compared to the current IVIg therapy used to treat inflammatory and autoimmune diseases.

(Visited 2 times, 1 visits today)
8
Like
Save

Comments

Comments are disabled for this post.